First Trust Advisors LP Sells 182,497 Shares of Enovix Co. (NASDAQ:ENVX)

First Trust Advisors LP trimmed its position in Enovix Co. (NASDAQ:ENVXFree Report) by 72.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 70,881 shares of the company’s stock after selling 182,497 shares during the period. First Trust Advisors LP’s holdings in Enovix were worth $770,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in ENVX. Barclays PLC increased its stake in shares of Enovix by 376.9% in the 3rd quarter. Barclays PLC now owns 252,012 shares of the company’s stock worth $2,353,000 after acquiring an additional 199,166 shares in the last quarter. Franklin Resources Inc. lifted its holdings in shares of Enovix by 81.4% during the third quarter. Franklin Resources Inc. now owns 79,559 shares of the company’s stock valued at $743,000 after purchasing an additional 35,711 shares during the last quarter. B. Riley Wealth Advisors Inc. purchased a new stake in shares of Enovix in the 3rd quarter worth approximately $117,000. Lpwm LLC bought a new stake in Enovix in the fourth quarter worth $549,000. Finally, Thurston Springer Miller Herd & Titak Inc. grew its stake in shares of Enovix by 36.3% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 47,625 shares of the company’s stock worth $518,000 after acquiring an additional 12,689 shares during the last quarter. Institutional investors own 50.92% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Rajendra K. Talluri sold 300,000 shares of the company’s stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $9.35, for a total value of $2,805,000.00. Following the completion of the transaction, the chief executive officer now owns 2,045,301 shares of the company’s stock, valued at approximately $19,123,564.35. This represents a 12.79 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 15.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ENVX. JPMorgan Chase & Co. dropped their price target on shares of Enovix from $10.00 to $9.00 and set an “overweight” rating on the stock in a research note on Thursday, May 1st. TD Securities cut their price target on shares of Enovix from $10.00 to $7.00 and set a “hold” rating on the stock in a report on Thursday, May 1st. Benchmark decreased their price objective on shares of Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a report on Tuesday, April 15th. B. Riley cut their target price on Enovix from $17.00 to $12.00 and set a “buy” rating on the stock in a research note on Tuesday, April 29th. Finally, Craig Hallum decreased their price target on Enovix from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Thursday, February 20th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $17.27.

Get Our Latest Report on Enovix

Enovix Trading Up 4.9 %

Shares of NASDAQ:ENVX opened at $6.48 on Friday. The stock’s 50-day simple moving average is $7.02 and its two-hundred day simple moving average is $9.20. The stock has a market capitalization of $1.24 billion, a price-to-earnings ratio of -4.47 and a beta of 1.99. Enovix Co. has a 52-week low of $5.27 and a 52-week high of $18.68. The company has a debt-to-equity ratio of 0.99, a quick ratio of 3.61 and a current ratio of 3.77.

Enovix (NASDAQ:ENVXGet Free Report) last announced its earnings results on Wednesday, February 19th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.01. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. The company had revenue of $9.72 million during the quarter, compared to analyst estimates of $8.77 million. Analysts expect that Enovix Co. will post -1.01 EPS for the current year.

About Enovix

(Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Further Reading

Institutional Ownership by Quarter for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.